FDA Investigator Frederick F Razzaghi

Frederick F Razzaghi has conducted inspections on 155 sites in 13 countries as of 06 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
155
Last Inspection Date:
06 May 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America, Canada, France, Sweden, Switzerland, United Kingdom of Great Britain and Northern Ireland, Ireland, Brazil, India, Bulgaria, Germany, Hungary, Denmark
FDA Investigators that have inspected at least one site in common with Frederick F Razzaghi:
Addam S Reynolds, Adetutu M Gidado, Aditi S Thakur, Akbar J Zaidi, Alberto A Viciedo, Alice S Tsao, Alicia M Mozzachio, Amy L Singer, Amy M Codella, Amy M Cramer, Andrew O Ejiofor, Angela E Glenn, Ankur C Patel, Ann Marie Montemurro, Anna Lazar, Anna M Brannen, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony C Warchut, Anthony J Donato, Arsen Karapetyan, Ashley J Burns, Ashutosh Rao, PhD, Asia D Clark, Atul J Agrawal, Audrey Thereset Uy, Azza Talaat, Barbara J Maulfair, Barbara Jwilimczyk Macri, Barbara M Frazier, Bei Yu, Brandon C Heitmeier, Brandy N Lepage, Brooke K Higgins, Brooke K Seeman, Bryan L Mcguckin, Byungja E Marciante, Carl A Huffman, III, Carole L Jones, Cassandra L Abellard, Catherine J Laufmann, Charles I Ann, Charles J Chacko, Cheryl A Clausen, Chiang Syin, PhD, Christina A Miller, Christina K Theodorou, Christina P Burkhart, Chunchun Zhang, Colleen F Hoyt, Courtney N Long, Craig D Zagata, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Dale A Nyberg, Dan Grabicki, Daniel J Grabicki, Daniel J Min, Daniel L Zheng, Darren S Brown, David A Oluwo, David E Bailey, David M Beltran, David S Jackson, Dawn L Wydner, Deborah B Nixon, Debra I Love, Demitria J Xiradakis, Denise M Visco, Investigator, Dennis Cantellops Paite, Devon Jenkins, Dhaval H Patel, Diane T Bargo, Diane T O'brien, Donald C Obenhuber, PhD, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Dr. Robert C Horan, MD, Dr. Yubing Tang, Edmund F Mrak, Jr, Edward O'shaughnessy, Edwin Melendez, Elaine E Gilfillan, Elizabeth M Jacobson, Emest F Bizjak, Emily A Baldwin, Emmanuel Jramos Maldonado, Eric M Mueller, PharmD, Eric Rothschild, Erin D Mccaffery, Esteban Beltran, Eufemia G Gonzalez, Evelyn Taha, Francis A Guidry, Frank J Marciniak, Fred Razzaghi, Gabrielle J Swain, Gam S Zamil, Geraldine D Sanders, Gianine E Tompkins, Gobiga Vanniyasingam, Graeme E Price, Guerlain Ulysse, Gwyn G Dickinson, Helen B Ricalde, Helen Verdel, Himanshu Gupta, PhD, Ivis L Negron, Jacob G Lutz, Jacqueline Mdiaz Albertini, James L Dunnie, Jr, James Norman, James P Mcreavey, James R Birkenstamm, Janet A Rajan, Jason F Chancey, Jason M Sluzynski, Jay B Shah, Jay T Wong, Jean Blackston Hill, Jean M Mulinde, MD, Jeffrey A Sommers, Jeffrey J Ebersole, Jennifer C Adams, Jennifer Macmillan, Jenny Sung, Jessica M Monteiro, Jessica S Estriplet, Joanne E King, Jogy George, John A Sciacchitano, Jonathan G Matrisciano, Jonathan S Helfgott, Jonathan W Chapman, Jonee J Mearns, Joohi Castelvetere, Jose A Lopez, Jose Acruz Gonzalez, Jose M Cayuela, Jose Ohernandez Guzman, Joseph Duca, Josh Renzo N Ramilo, Joy Rkozlowski Klena, Juanita P Versace, Justine Tomasso, Karen E D'orazio, Karishma G Gopaul, Kathleen R Jones, PhD, Keith M Reilly, Kelli F Dobilas, Kenneth M Gordon, Kent C Faul, Kevin P Foley, Kham Phommachanh, Kinh Q Mac, Ko U Min, Kristen E Rescigno, Kristina L Conroy, Kristy A Zielny, Kristy E Zuroski, Krystal O Ogunremi, Kwong P Lee, Lareese K Thomas, Lata C Mathew, PhD, Laura Fontan, MS, Laurel A Beer, Lauren L Vajo, Laurissa S Flowers, Lawrence Harmon, Jr, LCDR Anastasia M Piliafas Brown, LCDR Debra Emerson, Lcr Jayt Wong, Li Li, Liatte Kreuger, PharmD, Lily Y Koo, Linda M Cheny, Lisa L Flores, Lisa M Bellows, Lisa M Feola, Loretta Nemchik, Lori S Lawless, Luis A Dasta, Lydia I Rosas Marty, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcia Gelber, Marcus F Yambot, Marea K Harmon, Margaret M Sands, Maria A Bienkowski, Maria A Reed, Maria Estrella, Marie A Fadden, Marie B Buen Bigornia, Mark R Mcclain, Matthew B Casale, Matthew D Silverman, Mayar M Mussa, Melissa B Libby, Melissa J Garcia, Melissa T Roy, Meredith L Sheridan, Merideth K Rose, Meyer J Slobotsky, Michael Gurbarg, Michael L Casner, Michael R Goga, Michael R Klapal, Michael Serrano, Michele Perry Williams, Michelle M Parisi, Mikhail V Ovanesov, PhD, Miral B Patel, Monica E Murie, Monica M Mcclure, Monika Borkowska, Mra Davism, Mra Munizn, Mra V Millarw, Muralidhara B Gavini, PhD, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Naveen B Kanthamneni, Nealie C Newberger, Nerizza B Guerin, Nicholas A Violand, Nicholas L Paulin, Nicola M Fenty Stewart, Niketa Patel, Nikki S Ramirez, Nina Yang, Odera I Ekwunife, Pal S Mayasandra, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patricia A Morrow, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paul L Bellamy, Paul Mouris, Paula A Trost, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pratik S Upadhyay, DDC, Puspa Suresh Jayasekara, Rachel C Harrington, Rajiv R Srivastava, Ramon E Martinez, Randy L Self, Raymond L Cheung, Raymond T Oji, Rebecca Rodriguez, Regina T Brown, Richard E Needham, Richard H Penta, Richard J Muzeni, Robert C Steyert, Robin P Mathew, Rochelle L Cross, Roger F Zabinski, Rose Ljean Mary, Rose Xu, Russell J Glapion, Saleem A Akhtar, Samantha J Bradley, Samina S Khan, Samir C Gala, Samuel T Walker, Sandra A Hughes, Sandra Kershaw, Sangeeta M Khurana, PhD, Sarah Adella Fave, Sarah E Mcmullen, Sarah Forney, Satheesh K Podaralla, Satheesh Thomas, Sayyem H Akbar, Schultz, Sean G Casey, Sean R Marcsisin, Sena G Dissmeyer, Sergey S Akimov, Sharon K Thoma, PharmD, Sherri J Liu, Shirley S Wen, Shirshendu K Deb, PhD, Shusheen A Alexander, Simone E Pitts, Sinai I Davis, Sneha S Patel, Sony Mathews, Sonya M Edmonds, Srinivas R Chennamaneni, PhD, Stephanie Mangigian, MS/OSH, RN, Stephanie T Durso, Stephen C Smith, Stephen D Eich, Stephen J Koniers, Stephen J Mottola, Stephenie M Ortiz, Steven M Weinman, Steven P Donald, Suchan Kim, Susan M Halsted, Susan M Jackson, Susan T Hadman, Susanne M Richardson, MS RAC, Suzanne M Healy, Suzanne M Muchene, Syeda N Mahazabin, Taichun Qin, PhD, Tajah L Blackburn, Tamara S Rosbury, Tamil Arasu, PhD, Tania E Garcia, Tania E Vizcaino, Tanya R Syffrard, Tara G Bizjak, Tara R Gooen, Thai D Truong, Thomas J Arista, Tiffani D Wilson, Timothy T Kapsala, Tina M Pawlowski, Tonia F Bernard, Toyin B Oladimeji, Tricia S Martinez, Truong Xuan Nguyen (Andy), Tyanna N Hadley, Unnee Ranjan, Valerie C Reed, Victoria Spivak, Vidya B Pai, Vilmary Negron Rodriguez, Vipulchandra N Dholakia, Viviana Matta, Vlada Matusovsky, Wayne J Meyer, William J Leonard, William J Muszynski, William R Chang, Xiaokuang Lai, PhD, Yasamin Ameri, Ying Zhang, Yong Wu, PhD, Youmin Wang, Yumi J Hiramine, Yvesna C Blaise, Yvins Dezan, Yvonne E Lozano, Zhaohui Ye

Frederick F Razzaghi's Documents

Publish Date Document Type Title
March, 2018 FDA 483 AptaPharma Inc. - Form 483, 2018-03-16
May, 2015 FDA 483 Liberty Drug & Surgical - Form 483, 2015-05-22
March, 2010 FDA 483 Viant Medical, Inc. - Form 483, 2010-03-03
November, 2013 EIR Cosette Pharmaceuticals, Inc. - EIR, 2013-11-19
March, 2015 FDA 483 Response Quantum Analytics Group Inc. - Form 483R, 2015-04-03
January, 2017 EIR Primera Analytical Solutions Corporation - EIR, 2017-01-23
March, 2018 EIR AptaPharma Inc. - EIR, 2018-03-29
September, 2017 EIR Merck KGaA - EIR, 2017-09-08
May, 2019 FDA 483 Church & Dwight Co., Inc. - Form 483, 2019-05-23
June, 2010 FDA 483 Rutherford Chemicals, LLC - Form 483, 2010-06-04
April, 2016 FDA 483 RARITAN PHARMACEUTICALS INCORPORATED - Form 483, 2016-04-14
August, 2012 FDA 483 Suite K Value Added Services LLC - Form 483, 2012-08-20
June, 2010 FDA 483 Sonar Products, Inc. - Form 483, 2010-06-21
August, 2013 FDA 483 Vantage Specialty Ingredients, Inc - Form 483, 2013-08-20
February, 2019 FDA 483 Novitium Pharma LLC - Form 483, 2019-02-04
February, 2015 FDA 483 Renaissance Lakewood LLC - Form 483, 2015-02-06
September, 2014 FDA 483 Bentley Laboratories, LLC - Form 483, 2014-09-02
October, 2019 FDA 483 Aurolife Pharma LLC - Form 483, 2019-10-22
October, 2022 FDA 483 FAR Specialty Products, Inc. - Form 483, 2022-10-03
January, 2014 FDA 483 VILS Pharma Coating LLC - Form 483, 2014-01-27
April, 2013 EIR Alcami Corporation - EIR, 2013-04-09
April, 2017 FDA 483 Scientech Laboratories, Inc. - Form 483, 2017-04-25
August, 2015 FDA 483 Celgene Corporation - Form 483, 2015-08-04
April, 2017 EIR New Jersey Laboratories - EIR, 2017-04-12
September, 2021 FDA 483 Premier Trends LLC - Form 483, 2021-09-29
March, 2012 FDA 483 BASF Corporation - Form 483, 2012-03-30
June, 2017 FDA 483 Bentley Laboratories, LLC - Form 483, 2017-06-09
August, 2010 EIR Biovail Technologies, Ltd - EIR, 2010-08-27
April, 2010 FDA 483 Colgate-Palmolive Company - Form 483, 2010-04-30
December, 2014 FDA 483 Response BASF Corporation - Form 483R, 2014-12-16
February, 2015 EIR Excellentia International, LLC - EIR, 2015-02-27
February, 2012 FDA 483 davAgen Pharmaceutical, LLC - Form 483, 2012-02-27
August, 2013 EIR Vantage Specialty Ingredients, Inc - EIR, 2013-08-20
December, 2011 FDA 483 SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483, 2011-12-02
June, 2012 FDA 483 Guardian Drug Company - Form 483, 2012-06-08
February, 2015 FDA 483 Excellentia International, LLC - Form 483, 2015-02-27
June, 2012 FDA 483 New Jersey Laboratories - Form 483, 2012-06-29
April, 2016 EIR RARITAN PHARMACEUTICALS INCORPORATED - EIR, 2016-04-14
March, 2012 EIR BASF Corporation - EIR, 2012-03-30
January, 2017 FDA 483 Primera Analytical Solutions Corporation - Form 483, 2017-01-23
May, 2012 FDA 483 Davion, Inc - Form 483, 2012-05-10
April, 2018 FDA 483 Patheon Biologics (NJ) LLC - Form 483, 2018-04-09
February, 2018 FDA 483 Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. - Form 483, 2018-02-06
March, 2014 FDA 483 ACINO PRODUCTS LIMITED LIABILITY COMPANY - Form 483, 2014-03-05
December, 2014 FDA 483 BASF Corporation - Form 483, 2014-12-04
July, 2015 EIR APNAR PHARMA LLP - EIR, 2015-07-10
April, 2019 FDA 483 Perritt Laboratories, Inc - Form 483, 2019-04-19
October, 2011 FDA 483 Allcare Medical - Form 483, 2011-10-12
March, 2013 FDA 483 A.P. Deauville, LLC - Form 483, 2013-03-04
December, 2014 FDA 483 Cosmax Usa, Corporation - Form 483, 2014-12-22
May, 2014 FDA 483 Shiseido America Inc. - Form 483, 2014-05-12
June, 2021 FDA 483 MSN Pharmaceuticals Inc. - Form 483, 2021-06-16
June, 2016 EIR Appco Pharma LLC - EIR, 2016-06-27
February, 2015 EIR Renaissance Lakewood LLC - EIR, 2015-02-06
June, 2018 FDA 483 Aurolife Pharma LLC - Form 483, 2018-06-14
February, 2018 FDA 483 Response Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. - Form 483R, 2018-04-01
December, 2011 EIR SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - EIR, 2011-12-02
June, 2017 EIR Bentley Laboratories, LLC - EIR, 2017-06-09
February, 2020 FDA 483 Aurobindo Pharma Limited - Form 483, 2020-02-21
April, 2017 FDA 483 InvaTech Pharma Solutions LLC - Form 483, 2017-04-04
April, 2015 EIR CURIA NEW JERSEY LLC - EIR, 2015-04-06
February, 2010 FDA 483 Vertical Pharmaceuticals, LLC - Form 483, 2010-02-24
April, 2013 FDA 483 Alcami Corporation - Form 483, 2013-04-09
September, 2018 FDA 483 Curexa - East, LLC dba Curexa - Form 483, 2018-09-27
March, 2015 EIR Quantum Analytics Group Inc. - EIR, 2015-03-19
August, 2011 FDA 483 Renaissance Lakewood LLC - Form 483, 2011-08-10
February, 2011 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2011-02-17
May, 2018 FDA 483 CMIC CMO USA CORP - Form 483, 2018-05-08
March, 2015 FDA 483 Quantum Analytics Group Inc. - Form 483, 2015-03-19
December, 2013 FDA 483 AustarPharma LLC - Form 483, 2013-12-18
February, 2020 FDA 483 DR REDDY'S LABORATORIES LIMITED - Form 483, 2020-02-28
September, 2020 FDA 483 Carnegie Pharmaceuticals, LLC - Form 483, 2020-09-03
February, 2019 EIR Novitium Pharma LLC - EIR, 2019-02-04
February, 2016 EIR Amneal Pharmaceuticals LLC - EIR, 2016-02-19
April, 2024 FDA 483 Bell-More Labs Inc - Form 483, 2024-04-03
August, 2021 FDA 483 Coupler LLC - Form 483, 2021-08-26
June, 2014 FDA 483 Parfums Christian Dior - Form 483, 2014-06-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more